Moffitt Cancer Center awarded $3.4 million grant to establish imaging biomarker validation center

July 13, 2016

Early detection is one of the most effective strategies to save lives from most cancers. As part of a new U01 grant awarded to Jae K. Lee, PhD, Robert Gillies, PhD, John Heine, PhD and Matthew Schabath, PhD, the Moffitt Imaging Biomarker Validation Center (MIBVAC) will be established to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. Moffitt will also become a Clinical Validation Center for the National Cancer Institute's Early Detection Research Network.
-end-


H. Lee Moffitt Cancer Center & Research Institute

Related Prognosis Articles from Brightsurf:

Protein in blood may predict prognosis, recovery from stroke
Researchers at Mayo Clinic in Florida and collaborators have found that a biomarker in the blood may determine the extent of brain injury from different types of strokes and predict prognosis in these patients.

Risk score predicts prognosis of outpatients with COVID-19
A new artificial intelligence-based score considers multiple factors to predict the prognosis of individual patients with COVID-19 seen at urgent care clinics or emergency departments.

The number and clonality of TCRs are associated with the prognosis of colorectal cancer
This study has used a new technique called 'T-cell receptor (TCR) immuno-sequencing', which allows us to obtain both the number of T lymphocytes that infiltrate the tumor and their clonality index.

Tumour gene test could help to predict ovarian cancer prognosis
A global team of medical researchers led by UNSW have developed a test that could help to predict survival for women diagnosed with ovarian cancer, and pave the way towards personalised treatment.

HPV strains may impact cervical cancer prognosis
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumours caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.

A blood sample can be used to assess the severity and prognosis of FTLD in the future
Biomarkers to support the diagnosis of frontotemporal lobar degeneration (FTLD) and to assess the severity and expected prognosis of the disease are needed.

Study provides insights on treatment and prognosis of male breast cancer
A recent analysis reveals that treatment of male breast cancer has evolved over the years.

Does marital status affect prognosis after breast cancer diagnosis?
In a Cancer Medicine study of 298,434 patients diagnosed with breast cancer between 2004 and 2012, married patients had a better prognosis than patients who were single, who in turn had a better prognosis than those who were divorced, separated, or widowed.

Measuring chromosome imbalance could clarify cancer prognosis
Researchers have found that higher levels of aneuploidy lead to much greater lethality among prostate cancer patients.

The glass half-full: How optimism can bias prognosis in serious illness
A new study in the journal Psycho-Oncology, details how a seriously ill patient's optimism can impact a clinician's survival prognosis in palliative care conversations, impacting end-of-life decision-making and potentially, quality of life in the end-of-life setting.

Read More: Prognosis News and Prognosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.